查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829888

2025年全球肿瘤栓塞装置市场报告

Tumor Embolization Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肿瘤栓塞器械市场规模强劲成长，从2024年的14,936亿美元成长到2025年的15,874.8亿美元，复合年增长率为6.3%。这段时期的成长可归因于微创手术、技术进步、癌症发生率上升以及人口老化。

预计未来几年肿瘤栓塞器械市场规模将强劲成长，到2029年将达到22,546.7亿美元，复合年增长率为9.2%。预测期内的成长归因于个人化医疗、联合治疗、影像导引栓塞、远端医疗和远距会诊。预测期内的主要趋势包括栓塞剂、经动脉化疗栓塞术 (TACE)、安宁疗护栓塞以及影像导引手术的创新。

肿瘤栓塞装置是用于肿瘤治疗的微创装置。这些装置用于切断肿瘤的血液供应或将治疗药物直接输送到肿瘤部位。

肿瘤栓塞器械主要分为放射性和非放射性两类。非放射性栓塞器械包括用于肿瘤治疗的材料，例如发泡明胶、三丙烯酸明胶微球和聚乙烯醇 (PVA)。这些应用与癌性和非癌性肿瘤均相关，其终端用户包括医院、癌症治疗中心、加护病房和外科中心等。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供肿瘤栓塞设备的市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的肿瘤栓塞设备细分市场、市场趋势和机会，以及您在肿瘤栓塞设备行业取得成功所需的数据。本肿瘤栓塞设备市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年预测成长率为9.2%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。美国可能会直接感受到这一影响，因为校准微球和可分离栓塞线圈的供应链中断，这些产品主要来自爱尔兰和西班牙等主要地区，这可能导致介入性肿瘤手术的成本上升。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这一影响也可能波及更广泛的领域。

预计全球癌症发生率的上升将在预测期内推动肿瘤栓塞设备市场的成长。例如，英国最大的医疗保健慈善机构麦克米伦癌症援助组织在2022年10月预测，癌症患者数量将在2025年达到350万，2030年达到400万，2040年达到530万。因此，全球癌症发生率的上升可能会在未来几年刺激对肿瘤栓塞设备的需求。

不断增长的医疗支出推动了肿瘤栓塞器材市场的发展。医疗支出包括与提供医疗服务相关的所有费用，例如计划生育、营养计划和紧急医疗支援。医疗支出的成长推动了各种健康相关产品的发展，包括肿瘤栓塞器材。例如，根据英国预算责任办公室 (OBR) 和财政部（英国非政府公共机构）的经济预测，英国的医疗支出预计将从 2022/23 年的 1,820 亿英镑（2,317 亿美元）增加到 2024/25 年的 1,920 亿英镑（2,444.3 亿美元）。因此，医疗支出的上涨是推动肿瘤栓塞器材市场成长的关键因素。

肿瘤栓塞设备市场的主要参与者正在开发血管造影术系统等创新产品，以提高肿瘤标靶治疗的准确性和有效性。血管造影术系统是用于可视化血管和评估体内血流的专用影像工具。例如，2022 年 6 月，德国医疗保健公司西门子 (Siemens Hertiniers) 推出了 Artis Icono Ceiling。这款天花板血管造影术系统旨在提高肿瘤栓塞和其他介入手术的准确性。 Artis Icono Ceiling 具有快速获取3D(3D) 资料的功能，仅需 2.5 秒即可从患者头部获取影像，4 秒即可从侧面获取影像。这最大限度地减少了运动伪影并减少了对造影剂的需求。该系统的多功能性使其适用于各种专业，包括介入性放射学和心臟病学。

肿瘤栓塞设备市场的主要企业正致力于推出 Eye90 等创新疗法，以最大化市场收益。 Eye90 微球是一种 Y90 放射栓塞设备，专门用于治疗肝臟肿瘤，特别是肝细胞癌。 2023 年 5 月，加拿大医疗设备公司 ABK Biomedical 获得美国食品药物管理局(FDA) 的临床实验试验豁免 (IDE)核准，启动 Eye90 微球治疗肝细胞癌的多中心关键试验。微球采用专有製造製程生产，尺寸分布均匀，放射性浓度高。它们旨在向肿瘤发射高剂量的辐射，同时最大限度地减少对健康组织的照射。

2022 年 8 月，美国医疗设备製造商波士顿科学公司收购了美国栓塞凝胶开发商 Obsidio，以加强其介入性肿瘤学和栓塞产品组合。

肿瘤栓塞设备市场的主要企业包括波士顿科学公司、美敦力公司、泰尔茂公司、Sirtex Medical Limited、Merit Medical Systems Inc.、Cook Medical LLC、AngioDynamics Inc.、西门子医疗股份公司、强生公司、Penumbra Inc.、Teleflex Incorporated、Meril Life Sciences Pvt、强生公司、Penumbra Inc.、Teleflex Incorporated、Meril Life Sciences Pvt、Guer betvt、Stechnology. Inc.、Delcath Systems Inc.、Endoshape Inc.、InSitu Technologies Inc.、Monteris Medical Corporation、NeuWave Medical Inc.、Neoprobe Corporation、OncoSec Medical Incorporated、Helomics Corporation、Hologic、Surefire Medical Inc.、Varian Medical Systems Inc.

2024年，北美是肿瘤栓塞设备市场最大的地区。亚太地区是肿瘤栓塞设备市场的第二大地区。肿瘤栓塞设备市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

肿瘤栓塞设备市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。

肿瘤栓塞器械市场涵盖放射性和非放射性栓塞器械的销售。此市场的价值为出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肿瘤栓塞设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球肿瘤栓塞装置市场：成长率分析
  • 全球肿瘤栓塞设备市场表现：规模与成长，2019-2024
  • 全球肿瘤栓塞设备市场预测：规模与成长，2024-2029，2034
  • 全球肿瘤栓塞设备：总目标市场（TAM）

第六章 市场细分

  • 全球肿瘤栓塞设备市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 放射栓塞术
  • 非放射性栓塞剂
  • 全球肿瘤栓塞设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 癌症肿瘤
  • 非癌性肿瘤
  • 全球肿瘤栓塞设备市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 癌症治疗中心
  • 加护病房
  • 手术中心
  • 全球肿瘤栓塞设备市场：依放射栓塞剂（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 钇-90（Y-90）微球
  • 钬166微球
  • 全球肿瘤栓塞设备市场：依非放射性栓塞剂（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物释放型珠（DEB）
  • 微球（聚乙烯醇-PVA颗粒）
  • 明胶海绵
  • 液体栓塞剂（Onyx，黏合剂基）

第七章 区域和国家分析

  • 全球肿瘤栓塞设备市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肿瘤栓塞设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肿瘤栓塞装置市场：竞争格局
  • 肿瘤栓塞装置市场：公司简介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Cook Medical LLC
  • AngioDynamics Inc.
  • Siemens Healthineers AG
  • Johnson & Johnson
  • Penumbra Inc.
  • Teleflex Incorporated
  • Meril Life Sciences Pvt. Ltd.
  • Kaneka Corporation
  • Imagion Biosystems Ltd.
  • Guerbet
  • BTI Biotechnology Institute SL
  • BTG International
  • Avinger Inc.
  • Shape Memory Medical Inc.
  • Delcath Systems Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年肿瘤栓塞设备市场：提供新机会的国家
  • 2029年肿瘤栓塞设备市场：细分市场带来新机会
  • 2029年肿瘤栓塞设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32828u

Tumor embolization devices are minimally invasive instruments employed in the treatment of tumors. These devices serve the purpose of either occluding the blood supply to the tumor or delivering therapeutic agents directly to the tumor site.

The primary categories of tumor embolization devices include radioembolic agents and non-radioactive embolic agents. Non-radioactive embolic agents encompass materials like gelatin foam, tris-acryl gelatin microspheres, and polyvinyl alcohol (PVA) that are utilized in the treatment of tumors. These applications are relevant to both cancerous and noncancerous tumors, and the devices are employed by various end-users, including hospitals, cancer treatment centers, intensive care units, and surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tumor embolization devices market research report is one of a series of new reports from The Business Research Company that provides tumor embolization devices market statistics, including tumor embolization devices industry global market size, regional shares, competitors with a tumor embolization devices market share, detailed tumor embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor embolization devices industry. This tumor embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor embolization devices market size has grown strongly in recent years. It will grow from $1493.6 billion in 2024 to $1587.48 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population.

The tumor embolization devices market size is expected to see strong growth in the next few years. It will grow to $2254.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, image-guided embolization, telemedicine and remote consultations. Major trends in the forecast period include innovations in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, image-guided procedures.

The forecast of 9.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for calibrated microspheres and detachable embolization coils, sourced from key regions such as Ireland and Spain, could lead to higher costs for interventional oncology procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing global prevalence of cancer is expected to drive the growth of the tumor embolization devices market during the forecast period. For example, in October 2022, Macmillan Cancer Support, the largest healthcare charity in the UK, projected that the number of cancer cases would reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising cancer incidence worldwide is likely to fuel the demand for tumor embolization devices in the coming years.

The growth in healthcare expenditures is set to drive the tumor embolization devices market. Healthcare expenditures include all costs related to providing healthcare services, such as family planning, nutrition programs, and emergency health assistance. Increased spending in healthcare facilitates the development of various health-related products, including tumor embolization devices. For instance, according to economic forecasts from the Office for Budget Responsibility (OBR) and the Treasury, a UK-based non-departmental public body, the UK's health spending is expected to rise to £192 billion ($244.43 billion) in 2024/25, compared to £182 billion ($231.70 billion) in 2022/23. Thus, the increase in healthcare expenditures is a key factor driving the growth of the tumor embolization devices market.

Key players in the tumor embolization devices market are developing innovative products, such as angiography systems, to improve the accuracy and effectiveness of tumor-targeted treatments. Angiography systems are specialized imaging tools used to visualize blood vessels and evaluate blood flow within the body. For example, in June 2022, Siemens Healthineers, a Germany-based healthcare company, introduced the Artis Icono Ceiling. This ceiling-mounted angiography system is designed to enhance precision in tumor embolization and other interventional procedures. The Artis Icono Ceiling features rapid three-dimensional (3D) data acquisition, capturing images at the patient's head in just 2.5 seconds and from the sides in 4 seconds. This minimizes motion artifacts and reduces the need for contrast media. The system is versatile, making it suitable for various specialties, including interventional radiology and cardiology.

Major companies in the tumor embolization devices market are emphasizing the introduction of innovative treatments, such as Eye90, to maximize market revenue. Eye90 microspheres are a Y90 radioembolization device specifically designed for the treatment of liver tumors, particularly hepatocellular carcinoma. In May 2023, ABK Biomedical, a Canada-based medical device company, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a multicenter pivotal study of Eye90 microspheres in hepatocellular carcinoma. These microspheres are produced through a proprietary manufacturing process, resulting in uniform size distribution and high radioactivity concentration. They are designed to deliver a high dose of radiation to the tumor while minimizing exposure to healthy tissue.

In August 2022, Boston Scientific, a US-based medical device manufacturer, acquired Obsidio Inc. to strengthen its portfolio in interventional oncology and embolization. Obsidio is a US-based developer of embolization gel.

Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

North America was the largest region in the tumor embolization devices market in 2024. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor embolization devices market consists of sales of radioembolic agents and non-radioactive embolic agents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Embolization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Radioembolic Agents; Non-radioactive Embolic Agents
  • 2) By Application: Cancer Tumors; Noncancerous Tumors
  • 3) By End User: Hospitals; Cancer Treatment Centers; Intensive Care Units; Surgical Centers
  • Subsegments:
  • 1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres; Holmium-166 Microspheres
  • 2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs); Microspheres (Polyvinyl Alcohol - PVA Particles); Gelatin Sponges; Liquid Embolic Agents (Onyx, Glue-Based Agents)
  • Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Terumo Corporation; Sirtex Medical Limited; Merit Medical Systems Inc.; Cook Medical LLC; AngioDynamics Inc.; Siemens Healthineers AG; Johnson & Johnson; Penumbra Inc.; Teleflex Incorporated; Meril Life Sciences Pvt. Ltd.; Kaneka Corporation; Imagion Biosystems Ltd.; Guerbet; BTI Biotechnology Institute S.L.; BTG International; Avinger Inc.; Shape Memory Medical Inc.; Delcath Systems Inc.; Endoshape Inc.; InSitu Technologies Inc.; Monteris Medical Corporation; NeuWave Medical Inc.; Neoprobe Corporation; OncoSec Medical Incorporated; Helomics Corporation; Hologic; Surefire Medical Inc.; Varian Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Embolization Devices Market Characteristics

3. Tumor Embolization Devices Market Trends And Strategies

4. Tumor Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Embolization Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Embolization Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Embolization Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Embolization Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Embolization Devices Total Addressable Market (TAM)

6. Tumor Embolization Devices Market Segmentation

  • 6.1. Global Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radioembolic Agents
  • Non-radioactive Embolic Agents
  • 6.2. Global Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Tumors
  • Noncancerous Tumors
  • 6.3. Global Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cancer Treatment Centers
  • Intensive Care Units
  • Surgical Centers
  • 6.4. Global Tumor Embolization Devices Market, Sub-Segmentation Of Radioembolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Yttrium-90 (Y-90) Microspheres
  • Holmium-166 Microspheres
  • 6.5. Global Tumor Embolization Devices Market, Sub-Segmentation Of Non-radioactive Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Beads (DEBs)
  • Microspheres (Polyvinyl Alcohol - PVA Particles)
  • Gelatin Sponges
  • Liquid Embolic Agents (Onyx, Glue-Based Agents)

7. Tumor Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Embolization Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Embolization Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Embolization Devices Market

  • 8.1. Asia-Pacific Tumor Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Embolization Devices Market

  • 9.1. China Tumor Embolization Devices Market Overview
  • 9.2. China Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Embolization Devices Market

  • 10.1. India Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Embolization Devices Market

  • 11.1. Japan Tumor Embolization Devices Market Overview
  • 11.2. Japan Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Embolization Devices Market

  • 12.1. Australia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Embolization Devices Market

  • 13.1. Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Embolization Devices Market

  • 14.1. South Korea Tumor Embolization Devices Market Overview
  • 14.2. South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Embolization Devices Market

  • 15.1. Western Europe Tumor Embolization Devices Market Overview
  • 15.2. Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Embolization Devices Market

  • 16.1. UK Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Embolization Devices Market

  • 17.1. Germany Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Embolization Devices Market

  • 18.1. France Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Embolization Devices Market

  • 19.1. Italy Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Embolization Devices Market

  • 20.1. Spain Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Embolization Devices Market

  • 21.1. Eastern Europe Tumor Embolization Devices Market Overview
  • 21.2. Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Embolization Devices Market

  • 22.1. Russia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Embolization Devices Market

  • 23.1. North America Tumor Embolization Devices Market Overview
  • 23.2. North America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Embolization Devices Market

  • 24.1. USA Tumor Embolization Devices Market Overview
  • 24.2. USA Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Embolization Devices Market

  • 25.1. Canada Tumor Embolization Devices Market Overview
  • 25.2. Canada Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Embolization Devices Market

  • 26.1. South America Tumor Embolization Devices Market Overview
  • 26.2. South America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Embolization Devices Market

  • 27.1. Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Embolization Devices Market

  • 28.1. Middle East Tumor Embolization Devices Market Overview
  • 28.2. Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Embolization Devices Market

  • 29.1. Africa Tumor Embolization Devices Market Overview
  • 29.2. Africa Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Embolization Devices Market Competitive Landscape
  • 30.2. Tumor Embolization Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Cook Medical LLC
  • 31.2. AngioDynamics Inc.
  • 31.3. Siemens Healthineers AG
  • 31.4. Johnson & Johnson
  • 31.5. Penumbra Inc.
  • 31.6. Teleflex Incorporated
  • 31.7. Meril Life Sciences Pvt. Ltd.
  • 31.8. Kaneka Corporation
  • 31.9. Imagion Biosystems Ltd.
  • 31.10. Guerbet
  • 31.11. BTI Biotechnology Institute S.L.
  • 31.12. BTG International
  • 31.13. Avinger Inc.
  • 31.14. Shape Memory Medical Inc.
  • 31.15. Delcath Systems Inc.

32. Global Tumor Embolization Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Embolization Devices Market

34. Recent Developments In The Tumor Embolization Devices Market

35. Tumor Embolization Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Embolization Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Embolization Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Embolization Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer